{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:34:31Z","timestamp":1768811671613,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"name":"Bristol-Myers Squibb"},{"name":"IMEA foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1093\/jac\/dkw103","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T07:42:49Z","timestamp":1469086969000},"page":"2252-2261","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial)"],"prefix":"10.1093","volume":"71","author":[{"given":"Laurence","family":"Slama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Landman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambert","family":"Assoumou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Benalycherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assia","family":"Samri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pialoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Valin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Cabi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidonie","family":"Lambert-Niclot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,10]]},"reference":[{"key":"2016072100424119000_71.8.2252.1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . Department of Health and Human Services. https:\/\/aidsinfo.nih.gov\/guidelines ."},{"key":"2016072100424119000_71.8.2252.2","unstructured":"EACS Guidelines. 2014. http:\/\/eacsociety.org\/guidelines ."},{"key":"2016072100424119000_71.8.2252.3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/QAI.0b013e3182a99a0d","article-title":"Increases in duration of first highly active antiretroviral therapy over time (1996\u20132009) and associated factors in the Multicenter AIDS Cohort Study","volume":"65","author":"Slama","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2016072100424119000_71.8.2252.4","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31829cfbfa"},{"key":"2016072100424119000_71.8.2252.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2010.00857.x"},{"key":"2016072100424119000_71.8.2252.6","doi-asserted-by":"publisher","DOI":"10.1080\/09540120802183537"},{"key":"2016072100424119000_71.8.2252.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001510"},{"key":"2016072100424119000_71.8.2252.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61081-8"},{"key":"2016072100424119000_71.8.2252.9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830285fb"},{"key":"2016072100424119000_71.8.2252.10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/QAI.0b013e3181cae4a1","article-title":"Prospective, randomized, open label trial of efavirenz vs lopinavir\/ritonavir in HIV+ treatment-naive subjects with CD4+ <200 cell\/mm3 in Mexico","volume":"53","author":"Sierra-Madero","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2016072100424119000_71.8.2252.11","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu002"},{"key":"2016072100424119000_71.8.2252.12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23404"},{"key":"2016072100424119000_71.8.2252.13","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.865"},{"key":"2016072100424119000_71.8.2252.14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00098-06"},{"key":"2016072100424119000_71.8.2252.15","unstructured":"Desnoyer ADC , Katlama CV et al . Variability of darunavir plasma concentrations and relationships with adherence and virological response in the MONOI-ANRS136 trial. In: Abstracts of the Twelfth International Workshop on Clinical Pharmacology of HIV Therapy, Miami, FL, USA, 2011. Abstract #P32."},{"key":"2016072100424119000_71.8.2252.16","unstructured":"Gonzalez de Requena D , Bonora S , Canta F et al . Atazanavir Ctrough is associated with efficacy and safety: definition of therapeutic range. In: Abstracts of the Twelfth Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 2005. Abstract #645. Foundation for Retrovirology and Human Health, Alexandria, VA, USA."},{"key":"2016072100424119000_71.8.2252.17","first-page":"642","article-title":"2014 Update of the drug resistance mutations in HIV-1","volume":"22","author":"Wensing","year":"2014","journal-title":"Top Antivir Med"},{"key":"2016072100424119000_71.8.2252.18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu834"},{"key":"2016072100424119000_71.8.2252.19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01662-12"},{"key":"2016072100424119000_71.8.2252.20","doi-asserted-by":"crossref","first-page":"19070","DOI":"10.7448\/IAS.17.1.19070","article-title":"Lopinavir\/r no longer recommended as a first-line regimen: a comparative effectiveness analysis","volume":"17","author":"Potard","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2016072100424119000_71.8.2252.21","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1084"},{"key":"2016072100424119000_71.8.2252.22","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1719"},{"key":"2016072100424119000_71.8.2252.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181c990bf"},{"key":"2016072100424119000_71.8.2252.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833a2403"},{"key":"2016072100424119000_71.8.2252.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu773"},{"key":"2016072100424119000_71.8.2252.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064219"},{"key":"2016072100424119000_71.8.2252.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis188"},{"key":"2016072100424119000_71.8.2252.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60084-2"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/8\/2252\/16863854\/dkw103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T05:37:06Z","timestamp":1600925826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,10]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,7,21]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1093\/jac\/dkw103"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw103","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,10]]}}}